Lithium is NOT a standard or recommended treatment for hyperthyroidism
Lithium does not have an established role in the primary management of hyperthyroidism, and current guidelines do not recommend its use. The American Thyroid Association/American Association of Clinical Endocrinologists guidelines explicitly state there is "insufficient evidence to recommend the practice" of using lithium in hyperthyroidism treatment 1.
Why Lithium Is Not Recommended
The 2011 ATA/AACE guidelines acknowledge that historical reports suggested lithium pretreatment might reduce the radioactive iodine dose needed for Graves' disease and prevent thyroid hormone increases after antithyroid drug withdrawal. However, the guidelines conclude this approach "is not used widely, and there is insufficient evidence to recommend the practice" 1.
Standard Treatment Options Instead
The guideline-recommended treatments for hyperthyroidism are:
- Methimazole (10-20 mg daily initially, maintenance 5-10 mg daily) as first-line antithyroid drug therapy 1
- Propylthiouracil only in first trimester pregnancy, thyroid storm, or methimazole intolerance 1
- Radioactive iodine (10-15 mCi as single dose) 1
- Thyroidectomy by high-volume surgeon 1
When Lithium Has Been Used (Off-Label, Exceptional Circumstances)
Despite lack of guideline support, recent research suggests potential utility in very limited scenarios:
Dosing When Used Off-Label
When lithium has been employed in case reports and small studies:
- Dose range: 300-1000 mg daily (typically 900 mg/day in divided doses) 2, 3
- Target serum level: 0.4-0.8 mmol/L (notably lower than psychiatric therapeutic range of 0.6-1.2 mmol/L) 4, 5
- Duration:
Exceptional Clinical Scenarios Where It Has Been Reported
- Thionamide contraindication: Severe allergic reactions or hepatotoxicity to both methimazole and PTU 4, 7, 5
- Bridging to radioiodine: In severe Graves' disease after antithyroid drug withdrawal 6
- When all standard options unavailable: Cannot undergo surgery, radioiodine precautions impossible to maintain, pancytopenia precluding thionamides 5
Critical Caveats and Monitoring
If lithium is used in these exceptional circumstances:
- Monitor lithium levels every 3-5 days initially, targeting 0.4-0.8 mmol/L 4, 5
- Check renal function (creatinine, urinary density) - lithium causes early tubular effects 7
- Monitor calcium - hypercalcemia risk exists 7
- Assess thyroid function weekly (FT3, FT4, TSH) 6, 7
- Watch for lithium toxicity: tremor, ataxia, confusion, diarrhea 8
- Maintain adequate hydration (2500-3000 mL daily) and normal salt intake 8
Mechanism of Action
Lithium inhibits thyroid hormone release through multiple mechanisms: blocking iodine uptake via sodium-iodide symporter interference, inhibiting thyroglobulin proteolysis, and preventing TSH/TSI stimulation 5. This explains why it can temporarily control hyperthyroidism but is not curative.
Bottom Line
There is no established lithium dosing regimen for hyperthyroidism because it is not a recommended therapy. Use methimazole, radioiodine, or surgery per guidelines 1. Lithium remains an investigational, off-label option only when all standard therapies are contraindicated or unavailable, requiring intensive monitoring and subspecialty consultation.